PDL
EW icon

Portfolio Design Labs’s Edwards Lifesciences EW Stock Holding History

Portfolio Design Labs’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Buy
+2,668
New +$220K 0.04% 227

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Portfolio Design Labs's EW Position: Q1 2026 in Review

Portfolio Design Labs opened a new position in Edwards Lifesciences (EW) in Q1 2026: 2,668 shares worth $214K. The stake represents 0.04% of the portfolio and ranks #227 among its holdings.

1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Portfolio Design Labs held 2,668 shares of Edwards Lifesciences worth $214K as of Q1 2026.
  • Edwards Lifesciences was a new Portfolio Design Labs position in Q1 2026.
  • Edwards Lifesciences made up 0.04% of Portfolio Design Labs's portfolio in Q1 2026, its #227 holding.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Portfolio Design Labs's 13F filing for Q1 2026, filed 11 May 2026.